1. Home
  2. ENSC vs GPUS Comparison

ENSC vs GPUS Comparison

Compare ENSC & GPUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • GPUS
  • Stock Information
  • Founded
  • ENSC 2003
  • GPUS 1969
  • Country
  • ENSC United States
  • GPUS United States
  • Employees
  • ENSC N/A
  • GPUS N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • GPUS
  • Sector
  • ENSC Health Care
  • GPUS
  • Exchange
  • ENSC Nasdaq
  • GPUS NYSE
  • Market Cap
  • ENSC 2.9M
  • GPUS 3.4M
  • IPO Year
  • ENSC N/A
  • GPUS 1996
  • Fundamental
  • Price
  • ENSC $3.29
  • GPUS $1.71
  • Analyst Decision
  • ENSC
  • GPUS
  • Analyst Count
  • ENSC 0
  • GPUS 0
  • Target Price
  • ENSC N/A
  • GPUS N/A
  • AVG Volume (30 Days)
  • ENSC 4.9M
  • GPUS 109.1K
  • Earning Date
  • ENSC 05-12-2025
  • GPUS 05-19-2025
  • Dividend Yield
  • ENSC N/A
  • GPUS N/A
  • EPS Growth
  • ENSC N/A
  • GPUS N/A
  • EPS
  • ENSC N/A
  • GPUS N/A
  • Revenue
  • ENSC $5,210,031.00
  • GPUS $106,662,000.00
  • Revenue This Year
  • ENSC N/A
  • GPUS N/A
  • Revenue Next Year
  • ENSC N/A
  • GPUS N/A
  • P/E Ratio
  • ENSC N/A
  • GPUS N/A
  • Revenue Growth
  • ENSC 133.58
  • GPUS N/A
  • 52 Week Low
  • ENSC $1.62
  • GPUS $1.90
  • 52 Week High
  • ENSC $14.67
  • GPUS $20.30
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 55.92
  • GPUS N/A
  • Support Level
  • ENSC $3.02
  • GPUS N/A
  • Resistance Level
  • ENSC $4.85
  • GPUS N/A
  • Average True Range (ATR)
  • ENSC 0.40
  • GPUS 0.00
  • MACD
  • ENSC 0.27
  • GPUS 0.00
  • Stochastic Oscillator
  • ENSC 51.70
  • GPUS 0.00

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About GPUS HYPERSCALE DATA INC

Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has eight reportable segments: Energy and Infrastructure; Technology and Finance; SMC; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Disruptive.

Share on Social Networks: